Royal Bank of Canada’s Inspire Medical Systems INSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $13M | Buy |
252,971
+241,987
| +2,203% | +$16.9M | ﹤0.01% | 1736 |
|
|
2025
Q4 | $1.01M | Sell |
10,984
-2,928
| -21% | -$280K | ﹤0.01% | 3632 |
|
|
2025
Q3 | $1.03M | Buy |
13,912
+1,183
| +9% | +$120K | ﹤0.01% | 3958 |
|
|
2025
Q2 | $1.65M | Sell |
12,729
-20,040
| -61% | -$2.91M | ﹤0.01% | 3457 |
|
|
2025
Q1 | $5.22M | Buy |
32,769
+4,528
| +16% | +$819K | ﹤0.01% | 2224 |
|
|
2024
Q4 | $5.24M | Sell |
28,241
-1,923
| -6% | -$373K | ﹤0.01% | 2279 |
|
|
2024
Q3 | $6.37M | Sell |
30,164
-4,096
| -12% | -$712K | ﹤0.01% | 2098 |
|
|
2024
Q2 | $4.58M | Buy |
34,260
+21,241
| +163% | +$4.02M | ﹤0.01% | 2262 |
|
|
2024
Q1 | $2.8M | Buy |
13,019
+134
| +1% | +$26.3K | ﹤0.01% | 2655 |
|
|
2023
Q4 | $2.62M | Sell |
12,885
-18,177
| -59% | -$2.94M | ﹤0.01% | 2822 |
|
|
2023
Q3 | $6.16M | Sell |
31,062
-18,538
| -37% | -$4.68M | ﹤0.01% | 1942 |
|
|
2023
Q2 | $16.1M | Buy |
49,600
+33,369
| +206% | +$9.53M | ﹤0.01% | 1282 |
|
|
2023
Q1 | $3.8M | Sell |
16,231
-1,614
| -9% | -$408K | ﹤0.01% | 2295 |
|
|
2022
Q4 | $4.49M | Buy |
17,845
+4,826
| +37% | +$1.03M | ﹤0.01% | 2227 |
|
|
2022
Q3 | $2.31M | Sell |
13,019
-885
| -6% | -$178K | ﹤0.01% | 2724 |
|
|
2022
Q2 | $2.54M | Sell |
13,904
-7,392
| -35% | -$1.47M | ﹤0.01% | 2665 |
|
|
2022
Q1 | $5.47M | Sell |
21,296
-3,585
| -14% | -$819K | ﹤0.01% | 2186 |
|
|
2021
Q4 | $5.72M | Buy |
24,881
+3,899
| +19% | +$952K | ﹤0.01% | 2281 |
|
|
2021
Q3 | $4.89M | Sell |
20,982
-1,204
| -5% | -$251K | ﹤0.01% | 2306 |
|
|
2021
Q2 | $4.29M | Buy |
22,186
+5,081
| +30% | +$1.01M | ﹤0.01% | 2417 |
|
|
2021
Q1 | $3.54M | Buy |
17,105
+5,772
| +51% | +$1.23M | ﹤0.01% | 2514 |
|
|
2020
Q4 | $2.13M | Buy |
11,333
+9,708
| +597% | +$1.59M | ﹤0.01% | 2852 |
|
|
2020
Q3 | $210K | Buy |
1,625
+186
| +13% | +$20.5K | ﹤0.01% | 4517 |
|
|
2020
Q2 | $125K | Buy |
1,439
+898
| +166% | +$69K | ﹤0.01% | 4712 |
|
|
2020
Q1 | $33K | Sell |
541
-1,246
| -70% | -$92.2K | ﹤0.01% | 5336 |
|
|
2019
Q4 | $133K | Buy |
1,787
+1,347
| +306% | +$86.6K | ﹤0.01% | 4907 |
|
|
2019
Q3 | $27K | Sell |
440
-600
| -58% | -$39.5K | ﹤0.01% | 5367 |
|
|
2019
Q2 | $63K | Buy |
1,040
+890
| +593% | +$48K | ﹤0.01% | 5136 |
|
|
2019
Q1 | $9K | Sell |
150
-147
| -49% | -$7.94K | ﹤0.01% | 6035 |
|
|
2018
Q4 | $12K | Sell |
297
-29
| -9% | -$1.23K | ﹤0.01% | 5799 |
|
|
2018
Q3 | $14K | Buy |
326
+275
| +539% | +$12.9K | ﹤0.01% | 5852 |
|
|
2018
Q2 | $2K | Buy |
+51
| New | +$1.65K | ﹤0.01% | 6255 |
|
Other funds holding INSP
DM
VPM
VCM
Royal Bank of Canada's INSP Position: Q1 2026 in Review
Royal Bank of Canada increased its Inspire Medical Systems (INSP) stake by 2,203% in Q1 2026, buying an estimated $16.9M and bringing the position to 252,971 shares worth $13M. The position accounts for ﹤0.01% of the portfolio, ranked #1736.
Royal Bank of Canada first reported a position in INSP in Q2 2018 and has held it in 32 quarters since. The position peaked at $16.1M in Q2 2023. 301 funds tracked by Wall St. Rank hold INSP as of Q1 2026.
- Royal Bank of Canada held 252,971 shares of Inspire Medical Systems worth $13M as of Q1 2026.
- Royal Bank of Canada bought 241,987 Inspire Medical Systems shares in Q1 2026, an estimated $16.9M.
- Inspire Medical Systems made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #1736 holding.
- Royal Bank of Canada first reported a position in Inspire Medical Systems in Q2 2018 and has held it in 32 quarters since.
- Royal Bank of Canada's Inspire Medical Systems position peaked at $16.1M in Q2 2023.
- 301 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.